A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. (Q53656621)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. |
scientific article published in April 2003 |
Statements
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. (English)
Mark A Hoffman
John A Blessing
Samuel S Lentz
Gynecologic Oncology Group Study
1 April 2003
89
1
95-98